Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sara Martinez Breijo"'
Autor:
Urbano Anido-Herranz, Ovidio Fernandez-Calvo, Juan Ruiz-Bañobre, Sara Martinez-Breijo, Natalia Fernandez-Nuñez, Zulema Nogareda-Seoane, Miguel Garrido-Pumar, Javier Casas-Nebra, Gloria Muñiz-Garcia, Paula Portela-Pereira, Antonio Gomez-Caamaño, Daniel Adolfo Perez-Fentes, Lucia Santome-Couto, Martín Lázaro, Aurea Molina-Diaz, Ana Medina-Colmenero, Sergio Vazquez-Estevez
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionRadium-223 dichloride (Ra-223) is recommended as a treatment option for metastatic castration-resistant prostate cancer (mCRPC) patients with symptomatic bone metastases and no visceral disease, after docetaxel failure, or in patients who
Externí odkaz:
https://doaj.org/article/54152fa9facb47b9970ec092bda4d1a6
Autor:
Urbano Anido Herranz, Ovidio Fernandez Calvo, Sara Martinez Breijo, Natalia Fernández Núñez, Zulema Nogareda Seoane, Miguel Garrido Pumar, Javier Casas, Gloria Muñiz Garcia, Paula Portela Pereira, Antonio Gomez Caamaño, Daniel Pérez Fentes, Lucía Santomé, Gerardo Huidobro Vence, Aurea Molina Díaz, Ana Medina, Juan Ruiz Bañobre, Sergio Vázquez Estévez
Publikováno v:
Journal of Clinical Oncology. 41:96-96
96 Background: Radium-223 represents an option for symptomatic metastatic castration-resistant prostate cancer (mCRPC) after demonstrated an overall survival improvement in the ALSYMPCA trial. Radium-223 real-life experiences are scarce, particularly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7acfb99ee4de0d6fc1dbde2522278027
https://doi.org/10.1200/jco.2023.41.6_suppl.96
https://doi.org/10.1200/jco.2023.41.6_suppl.96
Autor:
Francisco, Gomez Veiga, Paula, Portela Pereira, Dario, Vazquez-Martul Pazos, Sonia, Pertega Diaz, Sara, Martinez Breijo, Cristina, Mendez Diaz, Esther, Rodríguez
Publikováno v:
Archivos espanoles de urologia. 67(5)
Active treatment in localized prostate cancer, in its various types, is assumed as a valid alternative. The effect of the possible overtreatment has raised that options such as active surveillance are offered as an alternative to active treatments, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3d0e34899cab630bc5562cbaab64a42
https://pubmed.ncbi.nlm.nih.gov/24914849
https://pubmed.ncbi.nlm.nih.gov/24914849
Autor:
Manuel Valladares Ayerbes, Luis M. Antón Aparicio, Paula Portela Pereira, Isabel Santamarina Cainzos, Francisco Gomez-Veiga, Sara Martinez Breijo, Dario Vazquez Pazos, Guadalupe Aparicio, Jose Gonzalez Dacal, Vanessa Medina Villaamil
Publikováno v:
RUNA. Repositorio da Consellería de Sanidade e Sergas
Servizo Galego de Saúde (SERGAS)
Servizo Galego de Saúde (SERGAS)
5087 Background: Recent studies have demonstrated that the aberrant expression of microRNAs (miRNAs)is related with the development of prostate cancer (PCa). Detection of circulating tumor cells (CTC) may provide diagnostic and prognostic information
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f8d4f2476c9ea540cb85734fd6ce9a
http://hdl.handle.net/20.500.11940/838
http://hdl.handle.net/20.500.11940/838
